Antithrombotic status and intracerebral hemorrhage in the setting of extracorporeal membrane oxygenation
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUNDNontraumatic intracerebral hemorrhage (ICH) is among the most devastating complications of extracorporeal membrane oxygenation (ECMO), and its management confronts an unresolved tension between hemorrhage extension and the thrombotic demands of the circuit.Antithrombotic status at the time of hemorrhage reflects underlying indication and illness severity, and the timing of ICH relative to cannulation may modify its prognostic significance.Large multicenter data examining outcomes by both antithrombotic status and hemorrhage timing are limited. AIMTo evaluate 30-day outcomes among patients with nontraumatic ICH in the setting of ECMO, stratified by recorded antithrombotic status at the index date and by the timing of hemorrhage relative to ECMO initiation. METHODSThis was a retrospective multicenter cohort study using the TriNetX Research Network Database (2016)(2017)(2018)(2019)(2020)(2021)(2022)(2023)(2024)(2025).Adults ≥ 18 years with ICH in the 30 days before or during ECMO were included in the analysis.Patients were stratified by recorded antithrombotic medication status at the index date: systemic anticoagulation (AC), dual therapy (DT; AC plus antiplatelet therapy), or no antithrombotic therapy (NT).Post-ICH antithrombotic management was not captured; discontinuation after ICH was presumed per standard practice but could not be verified.Primary outcome was 30-day mortality.Secondary outcomes were 30-day cardiac arrest and ischemic stroke; exploratory outcomes included blood transfusion and repeat ICH coding.Outcomes were evaluated across four ECMO windows: Pre-ECMO (-30 to 0 days), early (0-3 days), intermediate (3-14 days), and late (14-30 days).Hazard ratio (HR) was calculated for each predetermined outcome.All HRs in the setting of extracorporeal membrane oxygenation.
DOI: 10.5492/wjccm.126670
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7225889679
